Everhart Financial Group, Inc. Sorrento Therapeutics, Inc. Transaction History

Everhart Financial Group, Inc.

  • $444 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
SELL
$0.74 - $1.83 $740 - $1,830
-1,000 Reduced 8.53%
10,717 $9,000
Q2 2022

Jul 12, 2022
BUY
$1.24 - $2.33 $1,240 - $2,330
1,000 Added 9.33%
11,717 $24,000
Q2 2021

Jul 16, 2021
BUY
$6.35 - $10.0 $68,052 - $107,170
10,717 New
10,717 $104,000

Others Institutions Holding SRNE

# of Institutions
13
Shares Held
5.53M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Everhart Financial Group, Inc. Portfolio

Follow Everhart Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everhart Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Everhart Financial Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email